Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wedzicha, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wedzicha, W.
Topic Collections
Right arrowRelated Articles
Thorax 2004;59:913
© 2004 BMJ Publishing Group Ltd & British Thoracic Society

Airwaves

Wisia Wedzicha, Editor in Chief

The first 150 words of the full text of this article appear below.


DIFFICULT BACTERIA IN CF
Chronic airway infection with bacteria—particularly Gram-negative organisms such as Pseudomonas aeruginosa—predicts outcome in patients with cystic fibrosis. In this issue of Thorax we publish three papers about other Gram-negative bacteria that are found in the airways of these patients, together with an editorial by Elborn which discusses the clinical implication of these papers. The first paper by Jones and colleagues describes the outcome of infection with two genomovars of Burkholderia (multivorans and cenocepacia): patients with B multivorans had a similar mortality to those infected with P aeruginosa but a lower mortality than those with B cenocepacia infection. In the second paper Coenye and co-workers describe the transatlantic spread of a new B cenocepacia strain called PHDC previously identified in North America that has been found for the first time in a number of European countries. These two papers emphasise the importance of microbiological surveillance and careful infection . . . [Full text of this article]


Related Articles

Difficult bacteria, antibiotic resistance and transmissibility in cystic fibrosis
J S Elborn
Thorax 2004 59: 914-915. [Extract] [Full Text] [PDF]

Identifying failure of empirical treatment for pneumonia: vigilance and common sense
W-S Lim
Thorax 2004 59: 918-919. [Extract] [Full Text] [PDF]

Raised cord serum immunoglobulin E increases the risk of allergic sensitisation at ages 4 and 10 and asthma at age 10
A Sadeghnejad, W Karmaus, S Davis, R J Kurukulaaratchy, S Matthews, and S H Arshad
Thorax 2004 59: 936-942. [Abstract] [Full Text] [PDF]

Use of inhaled corticosteroids following discharge from an emergency department for an acute exacerbation of asthma
L Blais and M-F Beauchesne
Thorax 2004 59: 943-947. [Abstract] [Full Text] [PDF]

Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis
A M Jones, M E Dodd, J R W Govan, V Barcus, C J Doherty, J Morris, and A K Webb
Thorax 2004 59: 948-951. [Abstract] [Full Text] [PDF]

Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe
T Coenye, T Spilker, A Van Schoor, J J LiPuma, and P Vandamme
Thorax 2004 59: 952-954. [Abstract] [Full Text] [PDF]

Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome
R Menéndez, A Torres, R Zalacaín, J Aspa, J J Martín Villasclaras, L Borderías, J M Benítez Moya, J Ruiz-Manzano, F Rodríguez de Castro, J Blanquer, D Pérez, C Puzo, F Sánchez Gascón, J Gallardo, C Álvarez, and L Molinos
Thorax 2004 59: 960-965. [Abstract] [Full Text] [PDF]

Type of wine and risk of lung cancer: a case-control study in Spain
A Ruano-Ravina, A Figueiras, and J M Barros-Dios
Thorax 2004 59: 981-985. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & British Thoracic Society